![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Zaghloul Abdel-Azim Mustafa Fatima Siddiqui Afzal Khan Mansoor
Publisher: Informa Healthcare
ISSN: 1083-7450
Source: Pharmaceutical Development and Technology, Vol.11, Iss.3, 2006-09, pp. : 377-387
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Safety of Long-Term Bisphosphonate Therapy for the Management of Osteoporosis
Drugs, Vol. 71, Iss. 6, 2011-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Long-Term Safety of Bisphosphonate Therapy for Osteoporosis: A Review of the Evidence
Drugs & Aging, Vol. 23, Iss. 4, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Safety concerns with the long-term management of osteoporosis
Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Ubaidulla Udhumansha Khar R. K. Ahmad F. J. Tripathi Purnima
Pharmaceutical Development and Technology, Vol. 14, Iss. 1, 2009-01 ,pp. :